3/8
08:23 am
teva
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $14.00 price target on the stock.
Low
Report
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $14.00 price target on the stock.
3/8
08:11 am
teva
Rating for TEVA
Low
Report
Rating for TEVA
2/5
10:51 am
teva
Rating for TEVA
Low
Report
Rating for TEVA
2/5
10:51 am
teva
Rating for TEVA
Low
Report
Rating for TEVA
2/5
10:51 am
teva
Rating for TEVA
Low
Report
Rating for TEVA
2/5
08:45 am
teva
Rating for TEVA
Low
Report
Rating for TEVA
2/5
08:45 am
teva
Rating for TEVA
Low
Report
Rating for TEVA
1/29
07:03 am
teva
Rating for TEVA
Low
Report
Rating for TEVA
1/29
07:03 am
teva
Rating for TEVA
Low
Report
Rating for TEVA